Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report

Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report

We report an improvement in symptoms and quality of life with long-term use of guaifenesin for the treatment of mucus-related symptoms in a patient with chronic bronchitis, who presented with mucus hypersecretion, cough and dyspnea. Keywords: Guaifenesin, Chronic bronchitis, Chronic treatment, Mucin...

Full description

Bibliographic Details
Main Authors:	William W. Storms, Judi E. Miller
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	Respiratory Medicine Case Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213007118300376

Similar Items

Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report
by: William W. Storms, et al.
Published: (2018-01-01)

Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report
by: Ethan Singer, et al.
Published: (2019-01-01)

Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
by: Stott-Miller M, et al.
Published: (2020-10-01)

Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections
by: Helmut H. Albrecht, et al.
Published: (2017-12-01)

Susceptibility to chronic mucus hypersecretion, a genome wide association study.
by: Akkelies E Dijkstra, et al.
Published: (2014-01-01)

Revisited role for mucus hypersecretion in the pathogenesis of COPD
by: I. Cerveri, et al.
Published: (2010-06-01)

Correction: Susceptibility to chronic mucus hypersecretion, a genome wide association study.
by: Akkelies E Dijkstra, et al.
Published: (2015-01-01)

The role of ion channels in airway mucus hypersecretion in asthma
by: Arthur, Greer Kaylie
Published: (2015)

Association of the CFTR gene with asthma and airway mucus hypersecretion.
by: Astrid Crespo-Lessmann, et al.
Published: (2021-01-01)

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
by: Khan MA, et al.
Published: (2021-01-01)

Mucus hypersecretion in COPD: should we only rely on symptoms?
by: P-R. Burgel, et al.
Published: (2010-06-01)

Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells
by: Takeshi Shimizu, et al.
Published: (2012-01-01)

The Efficiecy of Nursing Protocol of Airway Clearance on the Patients with Mucus Hypersecretion
by: Shu-Chuan Ho, et al.
Published: (1996)

Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)
by: Shen Y, et al.
Published: (2018-01-01)

The effect of surfactant phospholipids on mucus hypersecretion in stimulated lung epithelial cells
by: Caillon, Fabienne
Published: (2005)

Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
by: Michael D. Kim, et al.
Published: (2021-01-01)

A pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis
by: Mayer Falcon, et al.
Published: (2019-03-01)

PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases
by: Yongchun Shen, et al.
Published: (2012-01-01)

CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial
by: Aili L. Lazaar, et al.
Published: (2020-06-01)

Secretoneurin Induces Airway Mucus Hypersecretion by Enhancing the Binding of EGF to NRP1
by: Rui Xu, et al.
Published: (2014-02-01)

The Effect of Heparin on Antigen-Induced Mucus Hypersecretion in the Nasal Epithelium of Sensitized Rats
by: Takao Ogawa, et al.
Published: (2013-01-01)

Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease
by: Victor Kim, et al.
Published: (2021-04-01)

Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation
by: Jang S, et al.
Published: (2012-03-01)

Successful long-term, adjunctive use of guaifenesin in a patient with a complex atopic medical history and primary immune deficiency: A case report
by: Bobby Quentin Lanier, et al.
Published: (2018-01-01)

Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis
by: Kristina Andelid, et al.
Published: (2021-06-01)

Lobeglitazone Attenuates Airway Inflammation and Mucus Hypersecretion in a Murine Model of Ovalbumin-Induced Asthma
by: Na-Rae Shin, et al.
Published: (2018-08-01)

Effect of Xiaoqinglong decoction on mucus hypersecretion in the airways and cilia function in a murine model of asthma
by: Mingyue Qi, et al.
Published: (2017-07-01)

The Study Of Processes Of Guaifenesin
by: Yu-Chu Hsu, et al.
Published: (1994)

A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion
by: Chakravorty I, et al.
Published: (2011-12-01)

Amelioration of Cigarette Smoke-Induced Mucus Hypersecretion and Viscosity by Dendrobium officinale Polysaccharides In Vitro and In Vivo
by: Rui Chen, et al.
Published: (2020-01-01)

Mucus Hypersecretion, MUC genes and Mucins in Inflammatory Nasosinusal Diseases. Regulation by Proinflammatory and Antiinflammatory Agents
by: Martínez Antón, Mª Asunción
Published: (2008)

Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019
by: Yuanfeng Zhang, et al.
Published: (2020-12-01)

Tbet Deficiency Causes T Helper Cell Dependent Airways Eosinophilia and Mucus Hypersecretion in Response to Rhinovirus Infection.
by: Nicholas Glanville, et al.
Published: (2016-09-01)

Lyn kinase represses mucus hypersecretion by regulating IL-13-induced endoplasmic reticulum stress in asthma
by: Xing Wang, et al.
Published: (2017-02-01)

Application of text mining to develop AOP-based mucus hypersecretion genesets and confirmation with in vitro and clinical samples
by: Emmanuel Minet, et al.
Published: (2021-03-01)

Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection
by: Tripathi S, et al.
Published: (2019-10-01)

Guaifenesin and increased sperm motility: a preliminary case report
by: Gary Means, et al.
Published: (2010-12-01)

β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling.
by: Yujiao Zhou, et al.
Published: (2014-01-01)

Kaempferol Inhibits Endoplasmic Reticulum Stress-Associated Mucus Hypersecretion in Airway Epithelial Cells And Ovalbumin-Sensitized Mice.
by: Sin-Hye Park, et al.
Published: (2015-01-01)

Hypersecretion glaucoma
by: Kalra B, et al.
Published: (1984-01-01)

Cannot write session to /tmp/vufind_sessions/sess_512horo7kug12rsftrdlhgk3lu